News

The study found that blood levels of two neurotoxic compounds dropped significantly in depressed patients after they were treated with the antidepressant escitalopram (Lexapro). The study, published in

The collaboration is focussed on developing future-generation utrophin modulators for the potential treatment of all patients with the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD). The research

The Department of Oncology at Vejle Hospital, under the leadership of professor Anders Jakobsen and in corporation with Dr. Torben Frøstrup Hansen, has been identified by the collaborators

As a result Nucala is now approved for use in the 31 European countries covered by the European Medicines Agency (EMA). Nucala is the first and only approved

Based on Thermo Fisher Scientific’s Oncomine Focus Assay, the AOP 50 Assay allows concurrent analysis of DNA and RNA from solid tumors, enabling sequencing of 35 hotspot genes

These detailed "fingerprints" show the surprising complexity of how these receptors activate their binding partners to produce a wide range of signaling actions. The study, which was published

The move affects the ongoing open label extension (OLE) part of the pivotal Phase 3 ZAF-311 bestPWS trial in patients with Prader-Willi syndrome (PWS). A complete clinical hold

Investors in the Series B financing round include the Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Foresite Capital and Kravis Investment Partners. ORIC will use the financing

The NDA submission was based on data from two bioavailability studies. The existing dosing for Viekira Pak is twice daily, three tablets in the morning and one in